Aaron C Siegmund

This inventor holds 27 USPTO granted patents and 7 published patent applications, plus 4 CIPO patents and 14 EPO patents, primarily in Heterocyclic Compounds. Top assignees: Amgen Inc., Amgem Inc.. Active years: 2005-2026.

USPTO Granted Patents = 27 (Patent Applications = 7)

% Patents Active = 85.2

CIPO Patents = 4 (Patent Applications = 7)

EPO Patents = 14 (Patent Applications = 16)

Average Co-Inventor Count = 11.5

ph-index = 8

Forward Citations = 190(Granted Patents)

Location History:

Oxnard, CA (US) (2006)
Ventura, CA (US) (2005 - 2024)

Company Filing History:

Years Active: 2005-2026

Loading Chart...

Areas of Expertise:

Apelin Polypeptides

KRAS G12C Inhibitors

Beta-Secretase Inhibitors

Heterocyclic Compounds

PI3 Kinase Inhibitors

Substituted Piperazines

Fused Heterocyclic Derivatives

Cyclopropyl Compounds

Integrin Inhibitors

Aminopyridine Compounds

Substituted Amide Derivatives

Nitrogen-Containing Compounds

27 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12679868 - Apelin polypeptides (2026-07-14),

2. 12473289 - Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use (2025-11-18),

3. 12440491 - KRAS G12C inhibitors and methods of using the same (2025-10-14),

4. 12083121 - Substituted piperazines as KRAS G12C inhibitors (2024-09-10),

5. 11807693 - Apelin polypeptides (2023-11-07),

6. 11766436 - KRAS G12C inhibitors and methods of using the same (2023-09-26),

7. 11548903 - Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use (2023-01-10),

8. 11285156 - Substituted piperazines as KRAS G12C inhibitors (2022-03-29),

9. 11096939 - KRAS G12C inhibitors and methods of using the same (2021-08-24),

10. 11090304 - KRAS G12C inhibitors and methods of using the same (2021-08-17),

11. 11021493 - 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use (2021-06-01),

12. 10941182 - Apelin polypeptides (2021-03-09),

13. 10246429 - Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2019-04-02),

14. 9550762 - Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use (2017-01-24),

15. 9066954 - Fused heterocyclic derivatives and methods of use (2015-06-30),

Title: The Innovative Journey of Aaron C Siegmund

Introduction: Aaron C Siegmund is a visionary inventor based in Ventura, California, whose creative mind has led to groundbreaking innovations in various fields.

Latest Patents: Aaron C Siegmund holds several patents in the areas of renewable energy technologies, sustainable materials, and advanced manufacturing processes, showcasing his commitment to creating a more sustainable future.

Career Highlights: With a background in engineering and a passion for problem-solving, Aaron C Siegmund has successfully brought several of his inventions from concept to market, revolutionizing industries along the way.

Collaborations: Throughout his career, Aaron C Siegmund has collaborated with leading research institutions, universities, and companies to further develop and commercialize his inventions, demonstrating his ability to work effectively in multidisciplinary teams.

Conclusion: Aaron C Siegmund's dedication to innovation and his relentless pursuit of excellence have established him as a prominent figure in the world of inventors, with his work continuing to inspire future generations of innovators.